ITEM#: 3042-171140650MG
MFR#: 1711406-50MG
Verapamil Related Compound B United States Pharmacopeia (USP) Reference Standard
Product Name | Description | Item# | QTY | |
---|---|---|---|---|
Verapamil Related Compound A | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-171130450MG | EA | |
Verapamil Related Compound E | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-171143950MG | EA | |
Verapamil Related Compound F | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-1711440150MG | EA | |
Verapamil Related Compound B Pharmaceutical Secondary Standard; Certified Reference Material | Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards | 3042-PHR2361100MG | EA | |
Verapamil Related Compound A Pharmaceutical Secondary Standard; Certified Reference Material | Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards | 3042-PHR2360100MG | EA | |
Meloxicam Related Compound B | Meloxicam Related Compound B United States Pharmacopeia (USP) Reference Standard | 3042-137942325MG | EA | |
Fenoldopam Related Compound B | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-126947020MG | EA | |
Oxandrolone Related Compound B | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-148202520MG | EA | |
Lufenuron Related Compound B | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issui | 3042-137072415MG | EA |
Thank you for visiting, your account is pending approval.
You will received email notification for approval within 24hrs.
Contact customerservice@franklinyoung.com for any questions.
Thank you for requesting an account with Franklin Young.
Your request has been declined
We restrict website access to government entities, and related customers.
Please contact customerservice@franklinyoung.com with any questions.